MD381C2 - Process for obtaining substituted aminodiacids, racemates thereof or optical isomers, or their pharmaceutically acceptable salts - Google Patents

Process for obtaining substituted aminodiacids, racemates thereof or optical isomers, or their pharmaceutically acceptable salts

Info

Publication number
MD381C2
MD381C2 MD95-0107A MD950107A MD381C2 MD 381 C2 MD381 C2 MD 381C2 MD 950107 A MD950107 A MD 950107A MD 381 C2 MD381 C2 MD 381C2
Authority
MD
Moldova
Prior art keywords
alkyl group
racemates
pharmaceutically acceptable
acceptable salts
optical isomers
Prior art date
Application number
MD95-0107A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Vincent Michel
Remond Georges
Laubie Michel
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26222007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD381(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR8021095A external-priority patent/FR2491469A1/en
Application filed by Adir filed Critical Adir
Publication of MD381C2 publication Critical patent/MD381C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

The invention relates to the process of obtaining substituted aminodiacids, racemates thereof or optical isomers or their pharmaceutically acceptable salts which possess an inhibition activity.The new obtained compounds possess valuable pharmacological properties.The process of obtaining substituted aminodiacids (racemates thereof or optical isomers or their pharmaceutically acceptable salts) is of general formula I:wherein A - is a benzenic cycle, n = 1;A - is a saturated cycle n = 0 or 1;R1 - is a lower alkyl group with 1 - 1 carbon atoms, comprising an aminogroup; R2 - hydrogen atom or alkyl group with 1 - 4 carbon atoms; R3 - linear or ramified alkyl group with 1 - 8 hydrogen atoms, mono- or dicycloalkyl - alkyl group or phenylalkyl group comprising totally 9 hydrogen atoms or substituted alkyl group of the formula:- (CH2)p - y - (CH)(R4)-R5,wherein R4 and R5 is hydrogen, lower alkyl with 1 - 4 hydrogen atoms or cycloalkyl with 3 - 6 hydrogen atoms; or R5 - alcoxycarbonyl, y = S or > N-Q, where Q- is hydrogen, acetyl or benzil - oxecarbonyl, p = 1 or 2, q = 0 or 1, racemates thereof or optical isomers or consisting pharmaceutically acceptable salts, consisting in the fact that the compound is of general formula II:wherein A, n, q have said values R+ +6 - is lower alkylradical or aminoalkyl radical, the aminofunction of which is protected by such radicals as benzil - oxycarbonyl or tretbutyloxycalbonyl, R+ 7 - hydroxy or lower alcoxy radicals, exposes to reaction the reductive alkylation with the compound of general formula III.wherein R2 and R3 have said values with the separation of the special product or removal in case of need of N - protective and ether groups by hydrogenolysis or saponification.
MD95-0107A 1980-10-02 1994-12-29 Process for obtaining substituted aminodiacids, racemates thereof or optical isomers, or their pharmaceutically acceptable salts MD381C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8021095A FR2491469A1 (en) 1980-10-02 1980-10-02 2-Carboxy-per:hydro-indole(s) and per or tetra:hydro-isoquinoline(s) - having a carboxy-substd. amino-acyl N-gp., inhibit carboxy:poly:peptidase(s), and kininase II and control hypertension
FR8106916A FR2503155A2 (en) 1980-10-02 1981-04-07 NOVEL SUBSTITUTED IMINO DIACIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR

Publications (1)

Publication Number Publication Date
MD381C2 true MD381C2 (en) 1996-05-31

Family

ID=26222007

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0107A MD381C2 (en) 1980-10-02 1994-12-29 Process for obtaining substituted aminodiacids, racemates thereof or optical isomers, or their pharmaceutically acceptable salts

Country Status (29)

Country Link
EP (1) EP0049658B1 (en)
JP (1) JPS5791974A (en)
KR (1) KR860001875B1 (en)
AR (1) AR242949A1 (en)
AT (1) ATE7910T1 (en)
AU (1) AU542611B2 (en)
CA (1) CA1341196C (en)
DD (1) DD201783A5 (en)
DE (1) DE3164201D1 (en)
DK (1) DK157011C (en)
EG (1) EG15361A (en)
ES (1) ES505999A0 (en)
FI (1) FI77230C (en)
FR (1) FR2503155A2 (en)
GE (1) GEP19970943B (en)
GR (1) GR75016B (en)
HU (1) HU185147B (en)
IE (1) IE51821B1 (en)
IL (1) IL63940A (en)
LU (1) LU88262I2 (en)
MD (1) MD381C2 (en)
NL (1) NL930046I2 (en)
NO (1) NO160780C (en)
NZ (1) NZ198535A (en)
OA (1) OA06914A (en)
PH (1) PH17516A (en)
PT (1) PT73755B (en)
SU (1) SU1153827A3 (en)
UA (1) UA6308A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3177130D1 (en) * 1980-08-30 1990-01-11 Hoechst Ag AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING THEM AND THE USE THEREOF.
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
LU88621I2 (en) * 1980-10-23 1995-09-01 Schering Corp Sandopril
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
IN156096B (en) * 1981-03-19 1985-05-11 Usv Pharma Corp
EP0065301A1 (en) * 1981-05-18 1982-11-24 Merck & Co. Inc. Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same
SU1327787A3 (en) * 1981-11-05 1987-07-30 Хехст Аг (Фирма) Method of producing cis,endo-2-azabicyclo-(3,3,0)-octane-3-carboxylic acids or acid-additive salts thereof
DE3226768A1 (en) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt DERIVATIVES OF CIS, ENDO-2-AZABICYCLO- (3.3.0) -OCTAN-3-CARBONIC ACID, METHOD FOR THE PRODUCTION THEREOF, THE MEANS CONTAINING THEM AND THE USE THEREOF
ATE25244T1 (en) * 1981-12-29 1987-02-15 Hoechst Ag NEW DERIVATIVES OF BICYCLIC AMINO ACIDS, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE, AS WELL AS NEW BICYCLIC AMINO ACIDS AS INTERMEDIATE STAGES AND PROCESS FOR THEIR PREPARATION.
CA1341296C (en) * 1981-12-29 2001-09-25 Hansjorg Urbach 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
DE3210496A1 (en) * 1982-03-23 1983-10-06 Hoechst Ag NEW DERIVATIVES OF BICYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF, THE MEANS CONTAINING THEM AND THE USE THEREOF, AND NEW BICYCLIC AMINO ACIDS AS INTERMEDIATE STAGES AND METHOD FOR THE PRODUCTION THEREOF
DE3302125A1 (en) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
HU191120B (en) * 1983-01-31 1987-01-28 Hoechts Ag,De Process for raceme separation of optically active byciclic imino-alpha-carbonic acid esthers
US5175306A (en) * 1983-01-31 1992-12-29 Hoechst Aktiengesellschaft Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters
DE3303344A1 (en) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING N-ALKYLATED AMINO ACIDS AND THEIR ESTERS
DE3333454A1 (en) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING N-ALKYLATED DIPEPTIDES AND THEIR ESTERS
DE3333455A1 (en) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING N-ALKYLATED DIPEPTIDES AND THEIR ESTERS
DE3408923A1 (en) * 1984-03-12 1985-09-26 Hoechst Ag, 6230 Frankfurt CARBOXYALKYLDIPEPTIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THE AGENTS CONTAINING THEM AND THE USE THEREOF
DE3413710A1 (en) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt METHOD FOR TREATING HEART INSUFFICIENCY
US5684016A (en) * 1984-04-12 1997-11-04 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency
DE3431541A1 (en) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt CIS, ENDO-2-AZABICYCLOALKAN-3-CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND INTERMEDIATE PRODUCTS IN THEIR PRODUCTION
GB8422165D0 (en) * 1984-09-01 1984-10-03 Wellcome Found Compounds
US5231080A (en) * 1985-10-15 1993-07-27 Hoechst Aktiengesellschaft Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
US4693996A (en) * 1985-12-23 1987-09-15 Warner-Lambert Company Method of treating heart failure and medicaments therefor
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
DE3633496A1 (en) * 1986-10-02 1988-04-14 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH CALCIUMANTAGONISTS AND THEIR USE IN MEDICINAL PRODUCTS
DE3639879A1 (en) * 1986-11-21 1988-06-01 Hoechst Ag METHOD FOR PRODUCING MONO, BI AND TRICYCLIC AMINO ACIDS, INTERMEDIATE PRODUCTS OF THIS METHOD, AND A METHOD FOR PRODUCING THE SAME
DE3722007A1 (en) * 1987-07-03 1989-01-12 Hoechst Ag METHOD FOR PRODUCING BICYCLIC AMINOCARBONIC ACIDS, INTERMEDIATE PRODUCTS OF THIS METHOD AND THE USE THEREOF
FR2620700B1 (en) * 1987-09-17 1990-06-01 Adir PROCESS FOR THE SYNTHESIS OF ALPHA AMINO ACIDS N ALKYLS AND THEIR ESTERS. APPLICATION TO THE SYNTHESIS OF CARBOXYALKYL DIPEPTIDES
FR2620709B1 (en) * 1987-09-17 1990-09-07 Adir PROCESS FOR THE INDUSTRIAL SYNTHESIS OF PERINDOPRIL AND ITS MAIN INTERMEDIATE SYNTHESIS
FR2620699B1 (en) * 1987-09-17 1990-06-01 Adir PROCESS FOR THE SYNTHESIS OF ALPHA AMINO N ALKYL ACIDS AND THEIR ESTERS. APPLICATION TO THE SYNTHESIS OF CARBOXYALKYL DIPEPTIDES
FR2620703B1 (en) * 1987-09-17 1991-10-04 Adir PROCESS FOR THE INDUSTRIAL SYNTHESIS OF PERHYDROINDOLE CARBOXYLIC ACID - 2 (2S, 3AS, 7AS). APPLICATION TO THE SYNTHESIS OF CARBOXYALKYL DIPEPTIDES
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
TW197945B (en) * 1990-11-27 1993-01-11 Hoechst Ag
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
ES2171768T3 (en) 1996-03-20 2002-09-16 Hoechst Ag OSEA RESORTION INHIBITORS AND VITRONECTINE RECEPTORS ANTAGONISTS.
FR2746394B1 (en) 1996-03-20 1998-05-29 Roussel Uclaf NOVEL TRICYCLIC COMPOUNDS, THEIR PREPARATION PROCESS, AND INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE19653647A1 (en) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin receptor antagonists, their preparation and their use
DE19741873A1 (en) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh New 5-ring heterocycles, their preparation, their use and pharmaceutical preparations containing them
DE19751251A1 (en) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituted imidazolidine derivatives, their manufacture, their use and pharmaceutical preparations containing them
DE19821483A1 (en) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
FR2807431B1 (en) * 2000-04-06 2002-07-19 Adir NOVEL PROCESS FOR THE SYNTHESIS OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
FR2807430B1 (en) * 2000-04-11 2002-05-17 Adir NOVEL PROCESS FOR THE SYNTHESIS OF N - [(S) -1- CARBOXYBUTYL] - (S) -ALANINE ESTERS AND APPLICATION TO THE SYNTHESIS OF PERINDOPRIL
AU2007203451B2 (en) * 2000-07-06 2010-09-02 Les Laboratoires Servier Pharmaceutical composition containing a crystalline form of perindopril tert-butylamine salt
FR2811318B1 (en) * 2000-07-06 2002-08-23 Adir NOVEL GAMMA CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRIL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2811320B1 (en) * 2000-07-06 2002-08-23 Adir NOVEL ALPHA CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRIL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2827860B1 (en) * 2001-07-24 2004-12-10 Servier Lab NOVEL PROCESS FOR SYNTHESIS OF ACID DERIVATIVES (2S, 3AS, 7AS) -1 - [(S) -ALANYL] -OCTAHYDRO-1H-INDOLE-2-CARBOXYLINE AND APPLICATION TO THE SYNTHESIS OF PERINDOPRIL
PT1333026E (en) * 2002-01-30 2007-09-17 Servier Lab Process for the preparation of high purity perindopril and intermediates useful in the synthesis
FR2838648B1 (en) * 2002-04-18 2004-05-21 Servier Lab NEW PERINDOPRIL SALT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
CN101333181A (en) 2003-06-24 2008-12-31 瑟维尔实验室 Novel crystalline forms of perindopril erbumine
DE60303101T2 (en) * 2003-06-30 2006-09-28 Les Laboratoires Servier Process for the synthesis of perindopril and its pharmaceutically acceptable salts
ES2272922T3 (en) * 2003-08-29 2007-05-01 Les Laboratoires Servier NEW SYNTHESIS PROCEDURE OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS.
PT1362845E (en) * 2003-09-01 2009-11-05 Servier Lab New process for the synthesis of n-((s)-1-carboxybutyl)-(s)-alanine esters and their use in the synthesis of perindopril
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
GB2413128A (en) * 2004-04-13 2005-10-19 Neopharma Ltd Process for the preparation of perindopril
SI21800A (en) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto New procedure of synthesis of perindopril
SI21881A (en) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. New crystal forms of perindopril erbumine hydrates, procedure of their preparation and pharmaceutical forms containing these compounds
EP1679072B9 (en) 2005-01-06 2009-09-02 IPCA Laboratories Limited Process for for synthesis of (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole-2- carboxylic acid derivatives and use in the synthesis of perindopril
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
FR2897866B1 (en) * 2006-02-28 2008-04-18 Servier Lab ALPHA CRYSTALLINE FORM OF PERINOPRIL ARGININE SALT, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
SI22543A (en) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto New salts of perindopril
GB0910692D0 (en) 2009-06-20 2009-08-05 Teva Pharma Compound
PT105315B (en) 2010-09-29 2013-01-16 Inst Superior Tecnico A NEW CRYSTALIN HYDRATE FORM OF PERINDOPRIL ERBUMINE, METHODS FOR PREPARATION AND USE IN PHARMACEUTICAL PREPARATIONS
FR2985512B1 (en) 2012-01-05 2014-06-20 Servier Lab PROCESS FOR THE PREPARATION OF L-ARGININE SALT OF PERINDOPRIL
FR2985511B1 (en) * 2012-01-05 2014-01-03 Servier Lab CRYSTALLINE DELTA FORM OF PERINOPRIL ARGININE SALT, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5572169A (en) * 1978-11-27 1980-05-30 Tanabe Seiyaku Co Ltd Isoquinoline derivative and its preparation
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
EP0018104B1 (en) * 1979-03-26 1983-05-25 Takeda Chemical Industries, Ltd. Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension
US4294832A (en) * 1979-04-28 1981-10-13 Tanabe Seiyaku Co., Ltd. Tetrahydroisoquinoline compounds and a pharmaceutical composition thereof
GB2048863B (en) * 1979-05-16 1983-06-15 Morton Norwich Products Inc Tetrahydroisoquinoline-3-carboxylic acids
US4303583A (en) * 1979-08-13 1981-12-01 American Home Products Corporation 1H,5H-[1,4]Thiazepino[4,3-a]indole-1,5-diones
FR2470767A1 (en) * 1979-12-07 1981-06-12 Science Union & Cie N-Acyl-2-carboxy fused ring heterocyclic cpds. - useful for inhibiting angiotensin converting enzyme and enkephalin(s)
FR2487829A2 (en) * 1979-12-07 1982-02-05 Science Union & Cie NOVEL SUBSTITUTED IMINO ACIDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
ZA811493B (en) * 1980-04-02 1982-03-31 Warner Lambert Co Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids
US4251444A (en) * 1980-04-07 1981-02-17 American Home Products Corporation Thiazepino-[4,3-b]-isoquinoline-1,5-dione derivatives and precursors
DE3177130D1 (en) * 1980-08-30 1990-01-11 Hoechst Ag AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING THEM AND THE USE THEREOF.
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Вейганд-Хильгетаг. Методы эксперимента в органической химии. М.,"Химия", 1968, p. 378. *

Also Published As

Publication number Publication date
HU185147B (en) 1984-12-28
GEP19970943B (en) 1997-04-18
KR860001875B1 (en) 1986-10-24
NO160780B (en) 1989-02-20
IL63940A0 (en) 1981-12-31
ES8305723A1 (en) 1983-04-16
AU7594981A (en) 1982-04-08
FI77230C (en) 1989-02-10
DD201783A5 (en) 1983-08-10
ATE7910T1 (en) 1984-06-15
FI77230B (en) 1988-10-31
FR2503155A2 (en) 1982-10-08
JPS5791974A (en) 1982-06-08
PT73755B (en) 1983-10-11
DE3164201D1 (en) 1984-07-19
LU88262I2 (en) 1994-02-03
PH17516A (en) 1984-09-13
FI813034L (en) 1982-04-03
NZ198535A (en) 1984-09-28
SU1153827A3 (en) 1985-04-30
IE51821B1 (en) 1987-04-01
NL930046I2 (en) 1994-01-03
FR2503155B2 (en) 1983-07-01
GR75016B (en) 1984-07-12
PT73755A (en) 1981-11-01
IE812257L (en) 1983-03-29
DK157011C (en) 1990-03-26
UA6308A1 (en) 1994-12-29
CA1341196C (en) 2001-03-06
OA06914A (en) 1983-05-31
IL63940A (en) 1985-06-30
DK157011B (en) 1989-10-30
EG15361A (en) 1987-04-30
ES505999A0 (en) 1983-04-16
AU542611B2 (en) 1985-02-28
DK434381A (en) 1982-04-03
KR830007564A (en) 1983-10-21
NO160780C (en) 1989-05-31
AR242949A1 (en) 1993-06-30
EP0049658B1 (en) 1984-06-13
JPH0132239B2 (en) 1989-06-29
EP0049658A1 (en) 1982-04-14
NL930046I1 (en) 1993-09-01
NO813339L (en) 1982-04-05

Similar Documents

Publication Publication Date Title
MD381C2 (en) Process for obtaining substituted aminodiacids, racemates thereof or optical isomers, or their pharmaceutically acceptable salts
AR247394A1 (en) 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
ES470470A1 (en) 1-Piperidinophthalazines as cardiac stimulants
HU911986D0 (en) Process for the production of cyclical amido-derivatives and the medical preparations containing them
ES8203388A1 (en) Imidazo-rifamycin derivatives with antibacterial utility
FR2354986A1 (en) PROCESS FOR SEPARATING AROMATIC HYDROCARBONS FROM MIXTURES OF ORGANIC COMPOUNDS
ES8300699A1 (en) Heterocyclic compounds
DK0482071T3 (en) New antiviral agents
GB1307315A (en) Fire retardant polyurethanes
ES422539A1 (en) Process for refining amines
PT75494A (en) Process for the preparation of dibenzymidazoazepine dibenzymidazoxazepine and dibenzymidazothiazepine compounds
BG48694A3 (en) Method for preparing alkandiol- dicarboxilates
FR2546515B1 (en) PROCESS FOR THE PREPARATION OF ADPDIETHYTLENIC CARBONYL COMPOUNDS
ES467861A1 (en) PROCEDURE FOR THE PREPARATION OF SPIRO-OXAZOLIDINES STEROI-DES AND ITS STEROISOMERS.
ES8205816A1 (en) Cardenolide-bis-digitoxoside derivatives, process for their preparation and their utilization as medicines.
ES425591A1 (en) A PROCEDURE FOR THE PREPARATION OF SECOPROSTAGLANDIAN.
ES378034A1 (en) Herbicidal halodinitro-1,3-phenylenediamine compounds
SE7600729L (en) PROSTAGLAND INFORMATIONS
FI811424L (en) CYCLIC AMIDER
ES8404334A1 (en) Intermediates for the preparation of 4-phenyl-1,3-benzodiazepins and methods for preparing the intermediates.
ES461252A1 (en) A PROCEDURE FOR THE PRODUCTION OF 4,5-EPOXY-TETRAHYDRO-PIRAN-3-ONA.
ES8506570A1 (en) Fungicidal isonicotinanilide acetal derivatives, process for their production and fungicides containing them.
KR850001742A (en) Process for preparing cumalic acid ester
ES469883A1 (en) 4-hydroxythiazolidine-2-thione derivatives
YU48445B (en) PROCEDURE FOR OBTAINING NEW 4-HYDROXYCUMARINE AND 1 3-INDANDION DERIVATIVES